Acacia Pharma Group plc
Acacia Pharma Group plc ACPH.BR Peers
See (ACPH.BR) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACPH.BR | $0.89 | N/A | N/A | -1.40 | -$0.64 | N/A |
| ARGX.BR | $507.00 | +0.52% | 30.96B | 34.65 | $14.63 | N/A |
| UCB.BR | $159.75 | +0.76% | 30.36B | 29.10 | $5.49 | +0.87% |
| TUB.BR | $125.60 | +1.62% | 5.59B | 61.87 | $2.03 | +0.83% |
| GLPG.AS | $24.66 | +1.07% | 1.63B | -9.03 | -$2.73 | N/A |
| GTBP.PA | $280.50 | N/A | 626.73M | -4.10 | -$68.39 | N/A |
| PHARM.AS | $0.87 | +1.81% | 591.87M | -43.50 | -$0.02 | N/A |
| MEDCL.PA | $15.66 | +2.29% | 517.86M | -14.37 | -$1.09 | N/A |
| VLA.PA | $2.89 | +0.70% | 483.06M | -5.16 | -$0.56 | N/A |
| IVA.PA | $2.79 | -2.62% | 387.05M | -0.90 | -$3.08 | N/A |
Stock Comparison
ACPH.BR vs ARGX.BR Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ARGX.BR has a market cap of 30.96B. Regarding current trading prices, ACPH.BR is priced at $0.89, while ARGX.BR trades at $507.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ARGX.BR's P/E ratio is 34.65. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ARGX.BR's ROE of +0.17%. Regarding short-term risk, ACPH.BR is less volatile compared to ARGX.BR. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs UCB.BR Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, UCB.BR has a market cap of 30.36B. Regarding current trading prices, ACPH.BR is priced at $0.89, while UCB.BR trades at $159.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas UCB.BR's P/E ratio is 29.10. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to UCB.BR's ROE of +0.11%. Regarding short-term risk, ACPH.BR is less volatile compared to UCB.BR. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs TUB.BR Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, TUB.BR has a market cap of 5.59B. Regarding current trading prices, ACPH.BR is priced at $0.89, while TUB.BR trades at $125.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas TUB.BR's P/E ratio is 61.87. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to TUB.BR's ROE of +0.05%. Regarding short-term risk, ACPH.BR is less volatile compared to TUB.BR. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs GLPG.AS Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, GLPG.AS has a market cap of 1.63B. Regarding current trading prices, ACPH.BR is priced at $0.89, while GLPG.AS trades at $24.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas GLPG.AS's P/E ratio is -9.03. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to GLPG.AS's ROE of -0.06%. Regarding short-term risk, ACPH.BR is less volatile compared to GLPG.AS. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs GTBP.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, GTBP.PA has a market cap of 626.73M. Regarding current trading prices, ACPH.BR is priced at $0.89, while GTBP.PA trades at $280.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas GTBP.PA's P/E ratio is -4.10. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to GTBP.PA's ROE of -4.68%. Regarding short-term risk, ACPH.BR is less volatile compared to GTBP.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs PHARM.AS Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, PHARM.AS has a market cap of 591.87M. Regarding current trading prices, ACPH.BR is priced at $0.89, while PHARM.AS trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas PHARM.AS's P/E ratio is -43.50. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to PHARM.AS's ROE of -0.06%. Regarding short-term risk, ACPH.BR is less volatile compared to PHARM.AS. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs MEDCL.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, MEDCL.PA has a market cap of 517.86M. Regarding current trading prices, ACPH.BR is priced at $0.89, while MEDCL.PA trades at $15.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas MEDCL.PA's P/E ratio is -14.37. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to MEDCL.PA's ROE of +0.66%. Regarding short-term risk, ACPH.BR is less volatile compared to MEDCL.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs VLA.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, VLA.PA has a market cap of 483.06M. Regarding current trading prices, ACPH.BR is priced at $0.89, while VLA.PA trades at $2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas VLA.PA's P/E ratio is -5.16. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to VLA.PA's ROE of -0.43%. Regarding short-term risk, ACPH.BR is less volatile compared to VLA.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs IVA.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, IVA.PA has a market cap of 387.05M. Regarding current trading prices, ACPH.BR is priced at $0.89, while IVA.PA trades at $2.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas IVA.PA's P/E ratio is -0.90. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to IVA.PA's ROE of +1.98%. Regarding short-term risk, ACPH.BR is less volatile compared to IVA.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ABVX.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ABVX.PA has a market cap of 336.21M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ABVX.PA trades at $5.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ABVX.PA's P/E ratio is -1.89. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ABVX.PA's ROE of -2.11%. Regarding short-term risk, ACPH.BR is less volatile compared to ABVX.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs DBV.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, DBV.PA has a market cap of 261.76M. Regarding current trading prices, ACPH.BR is priced at $0.89, while DBV.PA trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas DBV.PA's P/E ratio is -1.86. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to DBV.PA's ROE of -2.68%. Regarding short-term risk, ACPH.BR is less volatile compared to DBV.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ORY.MC Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ORY.MC has a market cap of 201.44M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ORY.MC trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ORY.MC's P/E ratio is -37.14. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ORY.MC's ROE of -0.04%. Regarding short-term risk, ACPH.BR is less volatile compared to ORY.MC. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs GNFT.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, GNFT.PA has a market cap of 183.72M. Regarding current trading prices, ACPH.BR is priced at $0.89, while GNFT.PA trades at $3.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas GNFT.PA's P/E ratio is 123.00. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to GNFT.PA's ROE of +0.02%. Regarding short-term risk, ACPH.BR is less volatile compared to GNFT.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ONWD.BR Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ONWD.BR has a market cap of 180.14M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ONWD.BR trades at $4.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ONWD.BR's P/E ratio is -5.04. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ONWD.BR's ROE of -1.08%. Regarding short-term risk, ACPH.BR is less volatile compared to ONWD.BR. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs IPH.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, IPH.PA has a market cap of 178.60M. Regarding current trading prices, ACPH.BR is priced at $0.89, while IPH.PA trades at $1.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas IPH.PA's P/E ratio is -3.18. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to IPH.PA's ROE of -2.63%. Regarding short-term risk, ACPH.BR is less volatile compared to IPH.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs NANO.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, NANO.PA has a market cap of 165.12M. Regarding current trading prices, ACPH.BR is priced at $0.89, while NANO.PA trades at $3.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas NANO.PA's P/E ratio is -2.43. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to NANO.PA's ROE of +0.77%. Regarding short-term risk, ACPH.BR is less volatile compared to NANO.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs HYL.BR Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, HYL.BR has a market cap of 162.96M. Regarding current trading prices, ACPH.BR is priced at $0.89, while HYL.BR trades at $5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas HYL.BR's P/E ratio is -25.30. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to HYL.BR's ROE of -0.19%. Regarding short-term risk, ACPH.BR is less volatile compared to HYL.BR. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs OSE.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, OSE.PA has a market cap of 133.17M. Regarding current trading prices, ACPH.BR is priced at $0.89, while OSE.PA trades at $5.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas OSE.PA's P/E ratio is 4.09. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to OSE.PA's ROE of +0.52%. Regarding short-term risk, ACPH.BR is less volatile compared to OSE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALCLS.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALCLS.PA has a market cap of 97.18M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALCLS.PA trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALCLS.PA's P/E ratio is -2.28. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALCLS.PA's ROE of -0.29%. Regarding short-term risk, ACPH.BR is less volatile compared to ALCLS.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALSEN.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALSEN.PA has a market cap of 92.25M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALSEN.PA trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALSEN.PA's P/E ratio is -3.41. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALSEN.PA's ROE of -0.33%. Regarding short-term risk, ACPH.BR is less volatile compared to ALSEN.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs MAAT.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, MAAT.PA has a market cap of 79.77M. Regarding current trading prices, ACPH.BR is priced at $0.89, while MAAT.PA trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas MAAT.PA's P/E ratio is -2.25. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to MAAT.PA's ROE of -1.61%. Regarding short-term risk, ACPH.BR is less volatile compared to MAAT.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs TNG.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, TNG.PA has a market cap of 77.31M. Regarding current trading prices, ACPH.BR is priced at $0.89, while TNG.PA trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas TNG.PA's P/E ratio is -2.02. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to TNG.PA's ROE of -4.66%. Regarding short-term risk, ACPH.BR is more volatile compared to TNG.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ADOC.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ADOC.PA has a market cap of 73.22M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ADOC.PA trades at $4.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ADOC.PA's P/E ratio is -4.05. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ADOC.PA's ROE of +1.28%. Regarding short-term risk, ACPH.BR is less volatile compared to ADOC.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ERYP.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ERYP.PA has a market cap of 48.66M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ERYP.PA trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ERYP.PA's P/E ratio is -80.10. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ERYP.PA's ROE of -0.73%. Regarding short-term risk, ACPH.BR is less volatile compared to ERYP.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs VVY.AS Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, VVY.AS has a market cap of 45.88M. Regarding current trading prices, ACPH.BR is priced at $0.89, while VVY.AS trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas VVY.AS's P/E ratio is -2.23. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to VVY.AS's ROE of -1.88%. Regarding short-term risk, ACPH.BR is less volatile compared to VVY.AS. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ABNX.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ABNX.PA has a market cap of 42.03M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ABNX.PA trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ABNX.PA's P/E ratio is -9.32. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ABNX.PA's ROE of -0.52%. Regarding short-term risk, ACPH.BR is more volatile compared to ABNX.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs COX.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, COX.PA has a market cap of 29.04M. Regarding current trading prices, ACPH.BR is priced at $0.89, while COX.PA trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas COX.PA's P/E ratio is -0.46. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to COX.PA's ROE of -0.43%. Regarding short-term risk, ACPH.BR is less volatile compared to COX.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALGEN.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALGEN.PA has a market cap of 28.67M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALGEN.PA trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALGEN.PA's P/E ratio is 12.52. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALGEN.PA's ROE of +0.10%. Regarding short-term risk, ACPH.BR is more volatile compared to ALGEN.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs FALG.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, FALG.PA has a market cap of 23.95M. Regarding current trading prices, ACPH.BR is priced at $0.89, while FALG.PA trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas FALG.PA's P/E ratio is -2.33. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to FALG.PA's ROE of -0.39%. Regarding short-term risk, ACPH.BR is less volatile compared to FALG.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs POXEL.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, POXEL.PA has a market cap of 23.63M. Regarding current trading prices, ACPH.BR is priced at $0.89, while POXEL.PA trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas POXEL.PA's P/E ratio is -1.10. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to POXEL.PA's ROE of +0.32%. Regarding short-term risk, ACPH.BR is less volatile compared to POXEL.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs DMSIM.BR Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, DMSIM.BR has a market cap of 23.09M. Regarding current trading prices, ACPH.BR is priced at $0.89, while DMSIM.BR trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas DMSIM.BR's P/E ratio is 0.09. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to DMSIM.BR's ROE of -0.57%. Regarding short-term risk, ACPH.BR is less volatile compared to DMSIM.BR. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALDVI.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALDVI.PA has a market cap of 21.94M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALDVI.PA trades at $1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALDVI.PA's P/E ratio is -3.72. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALDVI.PA's ROE of +0.44%. Regarding short-term risk, ACPH.BR is less volatile compared to ALDVI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs CYAD.BR Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, CYAD.BR has a market cap of 18.81M. Regarding current trading prices, ACPH.BR is priced at $0.89, while CYAD.BR trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas CYAD.BR's P/E ratio is -0.33. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to CYAD.BR's ROE of +0.91%. Regarding short-term risk, ACPH.BR is less volatile compared to CYAD.BR. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs AELIS.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, AELIS.PA has a market cap of 16.86M. Regarding current trading prices, ACPH.BR is priced at $0.89, while AELIS.PA trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas AELIS.PA's P/E ratio is -2.24. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to AELIS.PA's ROE of -0.74%. Regarding short-term risk, ACPH.BR is less volatile compared to AELIS.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALVAL.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALVAL.PA has a market cap of 16.68M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALVAL.PA trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALVAL.PA's P/E ratio is -1.67. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALVAL.PA's ROE of -0.74%. Regarding short-term risk, ACPH.BR is less volatile compared to ALVAL.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALNFL.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALNFL.PA has a market cap of 16.46M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALNFL.PA trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALNFL.PA's P/E ratio is -7.70. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALNFL.PA's ROE of -1.27%. Regarding short-term risk, ACPH.BR is less volatile compared to ALNFL.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALPHE.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALPHE.PA has a market cap of 15.83M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALPHE.PA trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALPHE.PA's P/E ratio is -2.67. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALPHE.PA's ROE of -0.64%. Regarding short-term risk, ACPH.BR is less volatile compared to ALPHE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALPAT.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALPAT.PA has a market cap of 12.34M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALPAT.PA trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALPAT.PA's P/E ratio is 11.11. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALPAT.PA's ROE of +0.01%. Regarding short-term risk, ACPH.BR is more volatile compared to ALPAT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs BAI.AS Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, BAI.AS has a market cap of 11.25M. Regarding current trading prices, ACPH.BR is priced at $0.89, while BAI.AS trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas BAI.AS's P/E ratio is -0.13. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to BAI.AS's ROE of -0.51%. Regarding short-term risk, ACPH.BR is less volatile compared to BAI.AS. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALVET.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALVET.PA has a market cap of 10.02M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALVET.PA trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALVET.PA's P/E ratio is -0.17. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALVET.PA's ROE of -0.32%. Regarding short-term risk, ACPH.BR is less volatile compared to ALVET.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALVIO.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALVIO.PA has a market cap of 9.85M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALVIO.PA trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALVIO.PA's P/E ratio is -0.46. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALVIO.PA's ROE of -2.09%. Regarding short-term risk, ACPH.BR is less volatile compared to ALVIO.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs APM.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, APM.PA has a market cap of 8.82M. Regarding current trading prices, ACPH.BR is priced at $0.89, while APM.PA trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas APM.PA's P/E ratio is -0.71. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to APM.PA's ROE of +0.08%. Regarding short-term risk, ACPH.BR is less volatile compared to APM.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALTHX.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALTHX.PA has a market cap of 8.76M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALTHX.PA trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALTHX.PA's P/E ratio is -4.96. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALTHX.PA's ROE of +7.08%. Regarding short-term risk, ACPH.BR is less volatile compared to ALTHX.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALTME.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALTME.PA has a market cap of 6.78M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALTME.PA trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALTME.PA's P/E ratio is -0.60. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALTME.PA's ROE of -8.99%. Regarding short-term risk, ACPH.BR is less volatile compared to ALTME.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALQGC.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALQGC.PA has a market cap of 5.00M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALQGC.PA trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALQGC.PA's P/E ratio is -0.09. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALQGC.PA's ROE of +14.01%. Regarding short-term risk, ACPH.BR is less volatile compared to ALQGC.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs LYS.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, LYS.PA has a market cap of 4.95M. Regarding current trading prices, ACPH.BR is priced at $0.89, while LYS.PA trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas LYS.PA's P/E ratio is -0.64. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to LYS.PA's ROE of -11.30%. Regarding short-term risk, ACPH.BR is less volatile compared to LYS.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALINT.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALINT.PA has a market cap of 4.04M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALINT.PA trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALINT.PA's P/E ratio is -15.25. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALINT.PA's ROE of -0.14%. Regarding short-term risk, ACPH.BR is less volatile compared to ALINT.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALHYG.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALHYG.PA has a market cap of 3.95M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALHYG.PA trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALHYG.PA's P/E ratio is -0.26. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALHYG.PA's ROE of -6.80%. Regarding short-term risk, ACPH.BR is less volatile compared to ALHYG.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALACT.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALACT.PA has a market cap of 3.94M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALACT.PA trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALACT.PA's P/E ratio is -0.22. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALACT.PA's ROE of +1.38%. Regarding short-term risk, ACPH.BR is less volatile compared to ALACT.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALBPS.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALBPS.PA has a market cap of 3.00M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALBPS.PA trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALBPS.PA's P/E ratio is -0.04. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALBPS.PA's ROE of +1.88%. Regarding short-term risk, ACPH.BR is less volatile compared to ALBPS.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs GNRO.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, GNRO.PA has a market cap of 2.00M. Regarding current trading prices, ACPH.BR is priced at $0.89, while GNRO.PA trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas GNRO.PA's P/E ratio is -0.11. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to GNRO.PA's ROE of +2.39%. Regarding short-term risk, ACPH.BR is less volatile compared to GNRO.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALMDP.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALMDP.PA has a market cap of 1.80M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALMDP.PA trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALMDP.PA's P/E ratio is -0.59. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALMDP.PA's ROE of +0.40%. Regarding short-term risk, ACPH.BR is less volatile compared to ALMDP.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALDEI.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALDEI.PA has a market cap of 1.13M. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALDEI.PA trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALDEI.PA's P/E ratio is -0.11. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALDEI.PA's ROE of +0.61%. Regarding short-term risk, ACPH.BR is less volatile compared to ALDEI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs BIOS.BR Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, BIOS.BR has a market cap of 979293.00. Regarding current trading prices, ACPH.BR is priced at $0.89, while BIOS.BR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas BIOS.BR's P/E ratio is -0.04. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to BIOS.BR's ROE of +0.34%. Regarding short-term risk, ACPH.BR is less volatile compared to BIOS.BR. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs OVXA.IR Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, OVXA.IR has a market cap of 856420.00. Regarding current trading prices, ACPH.BR is priced at $0.89, while OVXA.IR trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas OVXA.IR's P/E ratio is -0.21. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to OVXA.IR's ROE of -0.00%. Regarding short-term risk, ACPH.BR is more volatile compared to OVXA.IR. This indicates potentially higher risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs OXUR.BR Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, OXUR.BR has a market cap of 370593.00. Regarding current trading prices, ACPH.BR is priced at $0.89, while OXUR.BR trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas OXUR.BR's P/E ratio is N/A. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to OXUR.BR's ROE of -0.01%. Regarding short-term risk, ACPH.BR is less volatile compared to OXUR.BR. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALNEV.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALNEV.PA has a market cap of 10761.00. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALNEV.PA trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALNEV.PA's P/E ratio is N/A. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALNEV.PA's ROE of -2.24%. Regarding short-term risk, ACPH.BR is less volatile compared to ALNEV.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.
ACPH.BR vs ALPHA.PA Comparison
ACPH.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACPH.BR stands at N/A. In comparison, ALPHA.PA has a market cap of 1190.00. Regarding current trading prices, ACPH.BR is priced at $0.89, while ALPHA.PA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACPH.BR currently has a P/E ratio of -1.40, whereas ALPHA.PA's P/E ratio is -0.00. In terms of profitability, ACPH.BR's ROE is -1.55%, compared to ALPHA.PA's ROE of +0.83%. Regarding short-term risk, ACPH.BR is less volatile compared to ALPHA.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACPH.BR.